{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:08:56Z","timestamp":1794755336065,"version":"4.9.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuropharm.2024.110192","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:52:31Z","timestamp":1729057951000},"page":"110192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?"],"prefix":"10.1016","volume":"262","author":[{"given":"Hala","family":"Kawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8745-5902","authenticated-orcid":false,"given":"Ruoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110192_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105747","article-title":"The Janus face of HIF-1\u03b1 in ischemic stroke and the possible associated pathways","volume":"177","author":"Amin","year":"2024","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110192_bib2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCRESAHA.123.323371","article-title":"LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke","volume":"134","author":"Arkelius","year":"2024","journal-title":"Circulation Res"},{"key":"10.1016\/j.neuropharm.2024.110192_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105432","article-title":"MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice","volume":"161","author":"Arruri","year":"2022","journal-title":"Neurochem. Int."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110192_bib4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","article-title":"Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94","volume":"20","author":"Asahi","year":"2000","journal-title":"J Cere. Blood Flow Met."},{"key":"10.1016\/j.neuropharm.2024.110192_bib5","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib6","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1097\/00001756-200109170-00050","article-title":"Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia","volume":"12","author":"Asahi","year":"2001","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110192_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/jpm13071175","article-title":"The role of matrix metalloproteinases in hemorrhagic transformation in the treatment of stroke with tissue plasminogen activator","volume":"13","author":"Babenko","year":"2023","journal-title":"J Pers Med"},{"issue":"23","key":"10.1016\/j.neuropharm.2024.110192_bib8","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1523\/JNEUROSCI.0449-07.2007","article-title":"Neuron-specific inactivation of the hypoxia inducible factor 1\u03b1 increases brain injury in a mouse model of transient focal cerebral ischemia","volume":"27","author":"Baranova","year":"2007","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110192_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/jcbfm.2009.248","article-title":"Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement","volume":"30","author":"Bauer","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99577-2","article-title":"MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity","volume":"11","author":"Boumiza","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110192_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/cells12060884","article-title":"Ischemic Tolerance\u2014a way to reduce the extent of ischemia\u2013reperfusion damage","volume":"12","author":"Burda","year":"2023","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.neuropharm.2024.110192_bib13","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2024.110192_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2014.11.007","article-title":"Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways","volume":"64","author":"Carbone","year":"2015","journal-title":"Vascul. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110192_bib16","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1161\/STROKEAHA.120.033041","article-title":"Causal effect of MMP-1 (matrix metalloproteinase-1), MMP-8, and MMP-12 levels on ischemic stroke: a Mendelian randomization study","volume":"52","author":"C\u00e1rcel-M\u00e1rquez","year":"2021","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.0000046764.57344.31","article-title":"Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke","volume":"34","author":"Castellanos","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1012812","article-title":"Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration","volume":"16","author":"Challa","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep16951","article-title":"Role of P38 MAPK on MMP activity in photothrombotic stroke mice as measured using an Ultrafast MMP activatable Probe","volume":"5","author":"Chang","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110192_bib20","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1161\/STROKEAHA.115.011031","article-title":"Matrix metalloproteinase-12 induces blood\u2013brain barrier damage after focal cerebral ischemia","volume":"46","author":"Chelluboina","year":"2015","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib21","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1038\/srep09504","article-title":"Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage","volume":"5","author":"Chelluboina","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110192_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nbd.2008.12.010","article-title":"Early inhibition of HIF-1\u03b1 with small interfering RNA reduces ischemic\u2013reperfused brain injury in rats","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110192_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fcell.2018.00132","article-title":"Reactive Oxygen Species (ROS) formation in the brain at different oxygen Levels: role of hypoxia inducible factors","volume":"6","author":"Chen","year":"2018","journal-title":"Frontiers Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/CIRCGENETICS.108.834986","article-title":"Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels","volume":"2","author":"Cheng","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.neuropharm.2024.110192_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","article-title":"Novel drug targets for ischemic stroke identified through Mendelian randomization analysis of the blood proteome","volume":"140","author":"Chong","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2024.110192_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(97)00859-8","article-title":"Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia","volume":"238","author":"Clark","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.110192_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.0907606","article-title":"Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release","volume":"84","author":"Cuadrado","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib28","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1007\/s12035-022-02761-2","article-title":"Post-stroke impairment of the blood-brain barrier and perifocal vasogenic edema is alleviated by endovascular mesenchymal stem cell administration: Modulation of the PKCdelta\/MMP9\/AQP4-mediated pathway","volume":"59","author":"Datta","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110192_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110192_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.biocel.2012.01.023","article-title":"MMP9: a novel function in synaptic plasticity","volume":"44","author":"Dziembowska","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110192_bib31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jcp.24544","article-title":"Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia\u2010inducible factor\u20101 (HIF\u20101) dependent mechanism","volume":"229","author":"Engelhardt","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.neuropharm.2024.110192_bib32","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1074\/jbc.M512009200","article-title":"Individual Timp deficiencies differentially impact pro-MMP-2 activation","volume":"281","author":"English","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110192_bib33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41401-023-01061-2","article-title":"Angiogenesis after ischemic stroke","volume":"44","author":"Fang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World stroke Organization (WSO): Global stroke fact Sheet 2022","volume":"17","author":"Feigin","year":"2022","journal-title":"Int. J. Stroke"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110192_bib35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The Rebirth of matrix metalloproteinase inhibitors: Moving beyond the Dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcdb.2007.06.006","article-title":"MMPs as therapeutic targets--still a viable option?","volume":"19","author":"Fingleton","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110192_bib37","article-title":"Association of initial potassium levels with the type of stroke in the emergency department","volume":"30","author":"Fukaguchi","year":"2021","journal-title":"J Stroke and Cerebrovascular Dis"},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110192_bib38","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","article-title":"NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity","volume":"24","author":"Fujioka","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(99)01843-0","article-title":"Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion","volume":"842","author":"Fujimura","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110192_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-2094-11-96","article-title":"Impact of the neutrophil response to Granulocyte Colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke","volume":"11","author":"Gautier","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2024.110192_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.988283","article-title":"Cerebral edema after ischemic stroke: pathophysiology and underlying mechanisms","volume":"16","author":"Gu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib42","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.1563-05.2005","article-title":"A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia","volume":"25","author":"Gu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nbd.2006.02.006","article-title":"Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation","volume":"23","author":"Gurney","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12035-014-8996-y","article-title":"Matrix metalloproteinase-8 is a novel Pathogenetic factor in focal cerebral ischemia","volume":"53","author":"Han","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fped.2015.00033","article-title":"Hypoxia-inducible factor as an angiogenic master switch","volume":"3","author":"Hashimoto","year":"2015","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.neuropharm.2024.110192_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.801985","article-title":"Biological functions and regulatory mechanisms of hypoxia-inducible factor-1\u03b1 in ischemic stroke","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110192_bib47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/STROKEAHA.115.011258","article-title":"Matrix metalloprotease 3 exacerbates hemorrhagic transformation and worsens functional outcomes in hyperglycemic stroke","volume":"47","author":"Hafez","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00004647-199906000-00005","article-title":"Matrix metalloproteinases increase very early during experimental focal cerebral ischemia","volume":"19","author":"Heo","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110192_bib49","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/01.STR.0000073788.81170.1C","article-title":"Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure","volume":"34","author":"Heo","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2005.03.035","article-title":"Free radicals as triggers of brain edema formation after stroke","volume":"39","author":"Heo","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110192_bib51","doi-asserted-by":"crossref","first-page":"jcs261898","DOI":"10.1242\/jcs.261898","article-title":"Matrix metalloproteinases at a glance","volume":"137","author":"Hey","year":"2024","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135406","article-title":"Induced MRNA expression of matrix metalloproteinases Mmp-3, Mmp-12, and Mmp-13 in the infarct cerebral cortex of Photothrombosis model mice","volume":"739","author":"Hohjoh","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110192_bib53","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.011","article-title":"Disrupted ionic homeostasis in ischemic stroke and new therapeutic targets","volume":"26","author":"Hu","year":"2017","journal-title":"J. Stroke Cerebrovas. Dis."},{"key":"10.1016\/j.neuropharm.2024.110192_bib54","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1074\/jbc.M504988200","article-title":"Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal Transduction and induces matrix metalloproteinase-9 gene expression","volume":"281","author":"Hu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110192_bib55","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/STROKEAHA.113.002274","article-title":"MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death","volume":"44","author":"Inzitari","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib56","first-page":"1326","article-title":"Hemorrhagic transformation in acute ischemic stroke","volume":"30","author":"Jaillard","year":"1999","journal-title":"The MAST-E study. MAST-E Group. Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106720","article-title":"An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity","volume":"190","author":"Ji","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2024.110192_bib58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163","author":"Jiang","year":"2018","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110192_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J Cere Blood Flow & Met"},{"key":"10.1016\/j.neuropharm.2024.110192_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/jcbfm.2015.62","article-title":"Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain?","volume":"36","author":"Joutel","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110192_bib61","article-title":"Astrocyte mediated MMP-9 activation in the synapse dysfunction: an implication in Alzheimer disease","volume":"1","author":"Kamat","year":"2014","journal-title":"Ther Targets Neurol. Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110192_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110192_bib64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/00207454.2013.872102","article-title":"The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke","volume":"124","author":"Kurzepa","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fneur.2013.00032","article-title":"Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke","volume":"4","author":"Lakhan","year":"2013","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110192_bib66","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1161\/STROKEAHA.122.040144","article-title":"An unexplored role for MMP-7 (Matrix Metalloproteinase-7) in promoting gut permeability after ischemic stroke","volume":"53","author":"Larochelle","year":"2022","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110192_bib67","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cells9051076","article-title":"Structure and function of human matrix metalloproteinases","volume":"9","author":"Laronha","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110192_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107465","article-title":"The past, present and future perspectives of matrix metalloproteinase inhibitors","volume":"207","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110192_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/bc.bc_11_18","article-title":"Current progress in searching for clinically useful biomarkers of blood\u2013brain barrier damage following cerebral ischemia","volume":"4","author":"Liu","year":"2018","journal-title":"Brain Circulation"},{"key":"10.1016\/j.neuropharm.2024.110192_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.STR.0000105927.62344.4C","article-title":"Novel diagnostic test for acute stroke","volume":"35","author":"Lynch","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2016.03.016","article-title":"Matrix metalloproteinase-13 participates in neuroprotection and Neurorepair after cerebral ischemia in mice","volume":"91","author":"Ma","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"21","key":"10.1016\/j.neuropharm.2024.110192_bib72","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1021\/bi702496v","article-title":"Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch","volume":"47","author":"McCarthy","year":"2008","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110192_bib73","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.bbamcr.2017.04.011","article-title":"Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease","volume":"1864","author":"Meisel","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110192_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-8-93","article-title":"A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion","volume":"8","author":"Mitsios","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib75","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.32.8.1759","article-title":"Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment","volume":"32","author":"Montaner","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12975-018-0652-9","article-title":"MMP10 promotes efficient thrombolysis after ischemic stroke in mice with induced diabetes","volume":"10","author":"Navarro-Oviedo","year":"2019","journal-title":"Translational Stroke Res"},{"key":"10.1016\/j.neuropharm.2024.110192_bib77","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1212\/01.wnl.0000216133.98416.b4","article-title":"Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke","volume":"66","author":"Ning","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110192_bib78","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bbagen.2014.03.007","article-title":"Matrix metalloproteinases in inflammation","volume":"1840","author":"Nissinen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110192_bib79","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2174\/1570159X18666200528143301","article-title":"The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target","volume":"18","author":"Okada","year":"2020","journal-title":"Current Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2024.110192_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2018.02.012","article-title":"Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and Myeloperoxidase in ischemic stroke","volume":"271","author":"Palm","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2024.110192_bib81","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1902\/jop.2004.75.8.1068","article-title":"Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial","volume":"75","author":"Preshaw","year":"2004","journal-title":"J. Periodontol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110192_bib82","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.WCB.0000110532.48786.46","article-title":"Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1\u03b1 and HIF-2\u03b1 in a primary neuronal model of hypoxia","volume":"24","author":"Ralph","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110192_bib83","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain arrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuropharm.2024.110192_bib84","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/49.10.1733","article-title":"Early biomarkers of stroke","volume":"49","author":"Reynolds","year":"2003","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110192_bib85","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/jth.12312","article-title":"proMetalloproteinase\u201010 is associated with brain damage and clinical outcome in acute ischemic stroke","volume":"11","author":"Rodr\u00edguez","year":"2013","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.neuropharm.2024.110192_bib86","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1212\/01.wnl.0000247064.53130.91","article-title":"New-onset hypertension and inflammatory response\/poor outcome in acute ischemic stroke","volume":"67","author":"Rodr\u00edguez-Y\u00e1\u00f1ez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110192_bib87","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.107.500868","article-title":"MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke","volume":"39","author":"Rosell","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110192_bib88","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2021.01.003","article-title":"Matrix metalloproteinase-9 expression is enhanced by ischemia and tissue plasminogen activator and induces hemorrhage, disability and mortality in experimental stroke","volume":"460","author":"Saleem","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110192_bib89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11011-020-00573-8","article-title":"Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke","volume":"35","author":"Sarvari","year":"2020","journal-title":"Metabolic Brain Dis"},{"issue":"43","key":"10.1016\/j.neuropharm.2024.110192_bib90","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1074\/jbc.M117.806075","article-title":"Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation","volume":"292","author":"Scannevin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110192_bib91","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41386-021-00997-5","article-title":"The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study","volume":"47","author":"Seitz-Holland","year":"2022","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2024.110192_bib92","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fneur.2018.01103","article-title":"Efficacy of minocycline in acute ischemic stroke: a Systematic review and Meta-analysis of Rodent and clinical studies","volume":"9","author":"Sheng","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.661955","article-title":"Hemorrhagic transformation in ischemic stroke and the role of inflammation","volume":"12","author":"Spronk","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fneur.2013.00069","article-title":"Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke","volume":"4","author":"Sussman","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110192_bib95","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1538-7836.2007.02628.x","article-title":"Stromelysin-1 (MMP-3) is critical for Intracranial bleeding after t-PA treatment of stroke in mice","volume":"5","author":"Suzuki","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.neuropharm.2024.110192_bib96","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2009-02-203919","article-title":"Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of Lipoprotein Receptor-related protein","volume":"114","author":"Suzuki","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2024.110192_bib97","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.jcbfm.9600264","article-title":"Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study","volume":"26","author":"Tang","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2024.110192_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jocn.2022.11.018","article-title":"The efficacy and safety of alteplase treatment in patients with acute ischemic stroke with unknown time of onset: Real world data","volume":"107","author":"Terasawa","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib99","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fncel.2016.00056","article-title":"Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke","volume":"10","author":"Turner","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib100","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.022","article-title":"Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase","volume":"23","author":"Tsuruoka","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuropharm.2024.110192_bib101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jnc.13415","article-title":"MMP-9 in translation: from molecule to brain physiology, pathology, and therapy","volume":"139","author":"Vafadari","year":"2016","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110192_bib102","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1523\/JNEUROSCI.19-12-04994.1999","article-title":"Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum","volume":"19","author":"Vaillant","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib103","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2024.110192_bib104","article-title":"HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke","volume":"30","author":"Vatte","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110192_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103973","article-title":"Up-regulation of brain cytokines and metalloproteinases 1 and 2 contributes to neurological deficit and brain damage in transient ischemic stroke","volume":"129","author":"Victoria","year":"2020","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110192_bib106","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neuropharm.2024.110192_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112728","article-title":"Teriparatide induces angiogenesis in ischemic cerebral infarction zones of rats through AC\/PKA signaling and reduces ischemia-reperfusion injury","volume":"148","author":"Xiong","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110192_bib108","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol. Cell Physiol"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110192_bib109","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/jcbfm.2013.56","article-title":"Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery","volume":"33","author":"Yang","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuropharm.2024.110192_bib110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2015.04.024","article-title":"Matrix metalloproteinases as therapeutic targets for stroke","volume":"1623","author":"Yang","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110192_bib111","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2024.110192_bib112","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110192_bib113","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/jcbfm.2009.174","article-title":"Microglial low-Density Lipoprotein Receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2024.110192_bib114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm1387","article-title":"Role of matrix metalloproteinases in delayed Cortical responses after stroke","volume":"12","author":"Zhao","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2024.110192_bib115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.STR.0000253500.32979.d1","article-title":"Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke","volume":"38","author":"Zhao","year":"2007","journal-title":"Stroke"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T17:14:13Z","timestamp":1738430053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":114,"alternative-id":["S0028390824003617"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110192","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110192"}}